BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 12808655)

  • 1. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
    Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
    Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant tumors of the nasal cavity and paranasal sinuses.
    Katz TS; Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Villaret DB
    Head Neck; 2002 Sep; 24(9):821-9. PubMed ID: 12211046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esthesioneuroblastoma: is there a need for elective neck treatment?
    Demiroz C; Gutfeld O; Aboziada M; Brown D; Marentette LJ; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e255-61. PubMed ID: 21676553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esthesioneuroblastoma: the Northwestern University experience.
    Argiris A; Dutra J; Tseke P; Haines K
    Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.
    Kim HJ; Cho HJ; Kim KS; Lee HS; Kim HJ; Jung E; Yoon JH
    J Craniomaxillofac Surg; 2008 Jan; 36(1):47-52. PubMed ID: 18312791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
    Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
    Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors and outcome of esthesioneuroblastoma].
    Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retained role of surgery for olfactory neuroblastoma.
    Smee RI; Broadley K; Williams JR; Meagher NS; Bridger GP
    Head Neck; 2011 Oct; 33(10):1486-92. PubMed ID: 21928422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esthesioneuroblastoma: The Princess Margaret Hospital experience.
    Bachar G; Goldstein DP; Shah M; Tandon A; Ringash J; Pond G; Gullane PJ; Perez-Ordonez B; Gilbert RW; Brown DH; Gentili F; O'Sullivan B; Irish JC
    Head Neck; 2008 Dec; 30(12):1607-14. PubMed ID: 18798301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of 34 cases of esthesioneuroblastoma].
    Liu WS; Tang PZ; Xu GZ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 39(6):328-32. PubMed ID: 15469075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esthesioneuroblastoma of the nasal cavity.
    Hollen TR; Morris CG; Kirwan JM; Amdur RJ; Werning JW; Vaysberg M; Mendenhall WM
    Am J Clin Oncol; 2015 Jun; 38(3):311-4. PubMed ID: 23822985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.
    Kim HJ; Kim CH; Lee BJ; Chung YS; Kim JK; Choi YS; Yoon JH
    Auris Nasus Larynx; 2007 Dec; 34(4):493-8. PubMed ID: 17499464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esthesioneuroblastoma: the University of Iowa experience 1978-1998.
    Simon JH; Zhen W; McCulloch TM; Hoffman HT; Paulino AC; Mayr NA; Buatti JM
    Laryngoscope; 2001 Mar; 111(3):488-93. PubMed ID: 11224781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of failure and outcome in esthesioneuroblastoma.
    Dias FL; Sa GM; Lima RA; Kligerman J; Leoncio MP; Freitas EQ; Soares JR; Arcuri RA
    Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1186-92. PubMed ID: 14623748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage treatment of late neck metastasis in esthesioneuroblastoma: a meta-analysis.
    Gore MR; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1030-4. PubMed ID: 19841344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for esthesioneuroblastoma: is elective nodal irradiation warranted in the multimodality treatment approach?
    Noh OK; Lee SW; Yoon SM; Kim SB; Kim SY; Kim CJ; Jo KJ; Choi EK; Song SY; Kim JH; Ahn SD
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):443-9. PubMed ID: 20421144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.